Myriad Genetics' Q4, FY '09 Revenues Rise on MDx Sales Increase | GenomeWeb

NEW YORK (GenomeWeb News) – Myriad Genetics reported after the close of the market Monday that its fourth-quarter and fiscal-year 2009 revenues increased 33 percent and 47 percent, respectively, on increased sales of its molecular diagnostic products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.